IHE
Equity
iShares U.S. Pharmaceuticals ETF
- NAV as ofJun 03, 2026
- $89.7852 WK: 64.74 - 92.57
- 1 Day NAV Change as ofJun 03, 2026
- Increase $
0.86(0.96%)
- Jun 02, 2026
- YTD: Increase
5.25%
- Apr 30, 2026
- 1.25%
- Apr 30, 2026
- 1.70%
- Expense Ratio:Fees as stated in the prospectus
- 0.38%
- 4 stars
- NAV as ofJun 03, 2026
- $89.7852 WK: 64.74 - 92.57
- 1 Day NAV Change as ofJun 03, 2026
- Increase $
0.86(0.96%)
- Jun 02, 2026
- YTD: Increase
5.25%
- Apr 30, 2026
- 1.25%
- Apr 30, 2026
- 1.70%
- Expense Ratio:Fees as stated in the prospectus
- 0.38%
- 4 stars
The iShares U.S. Pharmaceuticals ETF seeks to track an index of U.S. companies in the pharmaceuticals sector. The fund offers a way for invstors to express a high-conviction view to domestic drug manufacturers and vaccine producers.
Key Facts
Net Assets of Fund
Closing Price
Exchange
NYSE Arca
Benchmark Index
Dow Jones U.S. Select Pharmaceuticals Index
Shares Outstanding
9,950,000
as of Jun 03, 2026